<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-105086</identifier>
<setSpec>0214-9168</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">No disponible</dc:title>
<dc:description xml:lang="en">Introduction High-fat diet intake is associated with cardiac disorders characterised by a low-grade inflammatory process which involves NF-&amp;#954;B activation. PPARbeta/delta has been proposed as a potential therapeutic target to mitigate the inflammatory process related to cardiovascular disorders. However, the involvement of this receptor in lipid-induced inflammatory response in the heart is not yet known (..) (AU)</dc:description>
<dc:creator>Davidson, Mercy M</dc:creator>
<dc:creator>Álvarez-Guardia, David</dc:creator>
<dc:creator>Michalik, Liliane</dc:creator>
<dc:creator>Vázquez-Carrera, Manuel</dc:creator>
<dc:creator>El Kochairi, Ilhem</dc:creator>
<dc:creator>Wahli, Walter</dc:creator>
<dc:creator>Palomer, Xavier</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción El consumo de dietas ricas en grasas se relaciona con alteraciones cardíacas caracterizadas por un proceso inflamatorio de baja intensidad mediado por NF-&amp;#954;B. PPARbeta/delta ha sido propuesto como potencial diana terapéutica para paliar el proceso inflamatorio asociado a alteraciones cardiovasculares. Sin embargo, se desconoce la implicación de este receptor en la respuesta inflamatoria inducida por lípidos en el corazón (..) (AU)</dc:description>
<dc:source>Clín. investig. arterioscler. (Ed. impr.);24(3): 131-140, mayo-jun. 2012. ilus, tab</dc:source>
<dc:identifier>ibc-105086</dc:identifier>
<dc:title xml:lang="es">PPARbeta/delta; atenúa la respuesta inflamatoria inducida por lípidos en el corazón a través de un mecanismo de transrepresión por antagonismo de receptores</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d8994</dc:subject>
<dc:subject>^d29061^s22031</dc:subject>
<dc:subject>^d31308</dc:subject>
<dc:subject>^d841</dc:subject>
<dc:subject>^d8230^s22020</dc:subject>
<dc:subject>^d10355^s22079</dc:subject>
<dc:subject>^d7426^s22032</dc:subject>
<dc:subject>^d32809^s22063</dc:subject>
<dc:subject>^d38773^s22079</dc:subject>
<dc:subject>^d28903^s22063</dc:subject>
<dc:subject>^d32175^s22002</dc:subject>
<dc:type>article</dc:type>
<dc:date>201206</dc:date>
</metadata>
</record>
</ibecs-document>
